|
September
4, 2001
Health
Wisconsin
Scientists
Produce
Blood
Cells From Stem Cells
By
ANTONIO REGALADO
Staff
Reporter of THE
WALL STREET
JOURNAL
Providing
some of the first evidence that stem cells from embryos
can be coaxed to form specific tissue types in the
laboratory, scientists at the University of
Wisconsin
have turned embryonic stem cells into oxygen-carrying red
blood cells and other components of human blood.
In
theory, embryonic stem cells have the potential to form
unlimited quantities of human cells for transplant
treatments, including blood for transfusions or bone
marrow to treat cancer patients. Now that President Bush
has given a limited go-ahead for federal funding of
stem-cell research, the pace of efforts to produce useful
tissues is expected to accelerate.
The
project to grow blood from stem cells began soon after
Wisconsin
scientists first isolated the primitive cells from embryos
in 1998, said Dan S. Kaufman, a doctor at the University
of Wisconsin Hospital and Clinics in
Madison
and the study's lead author.
Reporting
Tuesday in the journal Proceedings of the
National
Academy
of Sciences, the Wisconsin scientists describe how they
incubated embryonic stem cells alongside bone-marrow cells
from laboratory mice for several weeks. The mouse cells
provided chemical cues that encouraged a small percentage
of humanstem cells to grow into blood-system cells,
including white and red blood cells.
Experts
who have performed similar work using stem cells from
mouse embryos during the past decade said the study
confirmed their own results. Norman N. Iscove, a
researcher at the Ontario Cancer Institute in
Toronto
,
said the
Wisconsin
report "does not advance the fundamental
science" but the paper is a milestone, because
"every time biology in another species is confirmed
in humans, it is kind of an event."
He
said scientists have yet to prove that blood-system cells
created in the laboratory
are useful in treating disease, such as restoring the
damaged immune system of a leukemia patient who has
received radiation treatment. Dr. Iscove said such
transplants haven't succeeded in experiments on mice,
despite years of effort, because the lab-grown cells fail
to thrive. However, he held out the possibility that human
stem cells could behave differently.
Dr.
Kaufman said he is working on an experiment to grow human
bone marrow cells and then transplant them into mice. For
the time being, he said, "We are a long way off from anything clinically useful."
Stem-cell
work at
Wisconsin
is being conducted in an off-campus laboratory with
private financial support. "While
all this was swirling in
Washington
I have been working on this paper," said Dr. Kaufman,
who said he expects colleagues soon will publish strong
results on how to grow nerves from stem cells as well.
Write to Antonio Regalado at antonio.regalado@wsj.com
|